Mark Robertson-Tessi

Citado por

	Total	Desde 2020
Citas	2272	1705
Índice h	25	21
Índice i10	32	30

500

250

125

375

20072008200920102011201220132014201520162017201820192020202120222023202420256 6 5 9 8 6 21 22 26 59 100 127 159 186 253 308 420 489 47

Acceso público

Ver todo

35 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterDirección de correo verificada de moffitt.org
Jeffrey WestIntegrated Mathematical Oncology, Moffitt Cancer CenterDirección de correo verificada de moffitt.org
Chandler GatenbeeMoffitt Cancer CenterDirección de correo verificada de moffitt.org
Kimberly LuddyH. Lee Moffitt Cancer CenterDirección de correo verificada de moffitt.org
Jill GallaherResearch Scientist, Moffitt Cancer CenterDirección de correo verificada de moffitt.org
Maximilian A R StroblPostdoctoral Research Fellow, Cleveland Clinic, USADirección de correo verificada de ccf.org
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterDirección de correo verificada de moffitt.org
Ryan O. SchenckStanford Cancer Institute; Stanford UniversityDirección de correo verificada de stanford.edu
Joel S BrownMoffitt Cancer CenterDirección de correo verificada de darwiniandynamics.org
Mehdi DamaghiAssistant professor at Stony Brook medicine, dept of pathology and SB cancer centerDirección de correo verificada de stonybrookmedicine.edu
Alain GorielyUniversity of Oxford, Mathematical InstituteDirección de correo verificada de maths.ox.ac.uk
Heiko EnderlingProfessor, Radiation Oncology, Inst. for Data Science, MD Anderson Cancer Center, Houston, TX, USADirección de correo verificada de mdanderson.org
Yoganand (Yoga) BalagurunathanMoffitt Cancer CenterDirección de correo verificada de moffitt.org
Jan Poleszczuk, PhDNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of SciencesDirección de correo verificada de mimuw.edu.pl
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKDirección de correo verificada de icr.ac.uk
Mark LloydInspirata Inc.Dirección de correo verificada de inspirata.com
Jonathan W. WojtkowiakBlueprint Medicines; Previous Moffitt Cancer CenterDirección de correo verificada de blueprintmedicines.com

Seguir

Mark Robertson-Tessi

Integrated Mathematical Oncology, Moffitt Cancer Center

Dirección de correo verificada de moffitt.org - Página principal


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes M Robertson-Tessi, RJ Gillies, RA Gatenby, ARA Anderson Cancer research 75 (8), 1567-1579, 2015	307	2015
A mathematical model of tumor–immune interactions M Robertson-Tessi, A El-Kareh, A Goriely Journal of theoretical biology 294, 56-73, 2012	191	2012
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ... British journal of cancer 121 (7), 556-566, 2019	138	2019
Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ... Cancer research 77 (9), 2242-2254, 2017	137	2017
Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ... Cancer research 76 (5), 1009-1018, 2016	125	2016
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021	117	2021
The harsh microenvironment in early breast cancer selects for a Warburg phenotype M Damaghi, J West, M Robertson-Tessi, L Xu, MC Ferrall-Fairbanks, ... Proceedings of the National Academy of Sciences 118 (3), e2011342118, 2021	113	2021
Evolutionary dynamics of neoantigens in growing tumors E Lakatos, MJ Williams, RO Schenck, WCH Cross, J Househam, L Zapata, ... Nature genetics 52 (10), 1057-1066, 2020	113	2020
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ... PLoS computational biology 16 (3), e1007635, 2020	95	2020
Elastic growth models A Goriely, M Robertson-Tessi, M Tabor, R Vandiver Mathematical modelling of biosystems, 1-44, 2008	84*	2008
Normal tissue architecture determines the evolutionary course of cancer J West, RO Schenck, C Gatenbee, M Robertson-Tessi, ARA Anderson Nature communications 12 (1), 2060, 2021	76	2021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications medicine 2 (1), 46, 2022	64	2022
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse Frontiers in immunology 5, 429, 2014	54	2014
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023	50	2023
Stochasticity in the genotype-phenotype map: implications for the robustness and persistence of bet-hedging D Nichol, M Robertson-Tessi, P Jeavons, ARA Anderson Genetics 204 (4), 1523-1539, 2016	47	2016
Virtual alignment of pathology image series for multi-gigapixel whole slide images CD Gatenbee, AM Baker, S Prabhakaran, O Swinyard, RJC Slebos, ... Nature communications 14 (1), 4502, 2023	45*	2023
Agent-based methods facilitate integrative science in cancer J West, M Robertson-Tessi, ARA Anderson Trends in cell biology 33 (4), 300-311, 2023	42	2023
Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues C Gabbutt, RO Schenck, DJ Weisenberger, C Kimberley, A Berner, ... Nature biotechnology 40 (5), 720-730, 2022	42	2022
The goldilocks window of personalized chemotherapy: getting the immune response just right DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ... Cancer research 79 (20), 5302-5315, 2019	42	2019
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1798, 2022	36	2022

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores